Development of ONCR-177, an armed oncolytic HSV-1 designed for potent and systemic stimulation of antitumor immunity

Development of ONCR-177, an armed oncolytic HSV-1 designed for potent and systemic stimulation of antitumor immunity

Wednesday, October 21, 2020 7:10 AM to 7:40 AM · 30 min. (Africa/Abidjan)
Immuno-Oncology

Log in